Dr. Elizabeth Liedhegner works with student in her lab.

Alterations in cellular signaling mechanisms are the crux of pathological disease development and progression. Understanding of such mechanisms impact future therapeutic development and disease management with the goal of enhancing the quality of life for the patient. The goals of the Liedhegner laboratory are centered on identification of molecular signaling pathways in the pathogenesis of disease to discover new targets for disease diagnosis, prognosis, and therapeutics while developing the next generation of scientists. 

The current, ongoing research within the laboratory focuses on the development of novel therapeutics for anxiety and post-traumatic stress disorder through enhanced understanding of cellular signaling within the endocannabinoid system.  A second project is aimed at understanding the signaling mechanisms of photobiomodulation in a cellular model of diabetic retinopathy.  


Elizabeth Liedhegner, Ph.D.

2400 E. Hartford Ave.
Enderis Hall, Room B84
Milwaukee, WI 53211